National Medical Care Co. · TADAWUL:4005
National Medical Care — 9M 2025 Earnings Presentation
19 slides from National Medical Care's earnings presentation, Nov 2, 2025
Slide 1: Earnings Presentation 9M 2025
Earnings Presentation 9M 2025 2 November 2025 | Riyadh, KSA
Slide 2: Performance Highlights and Strategy
Performance Highlights and Strategy Care Medical Earnings Presentation – 2/11/2025 2
Slide 3: Operating and Financial Performance Highlights
Operating and Financial Performance Highlights Strong financial and operational results for the first nine months of 2025, driven by record-breaking revenue in Q3 and broad-based growth across Care’s hospital network Revenue 9M 2025 1196 710.8 Total patients 9M 2025 New facility with significant str
Slide 4: Strategic Focus: Expansion, New Services, Efficiency, and Automation
Strategic Focus: Expansion, New Services, Efficiency, and Automation Overview of strategic initiatives Home Healthcare Services Executive Health Check ReLib Mental Health Center New Services Started Home Healthcare Services to increase patient Launched executive health check to raise cash Introduced
Slide 5: Operating and Financial Performance
Operating and Financial Performance 9M 2025 Care Medical Earnings Presentation – 2/11/2025 5
Slide 6: Operational Trends
Operational Trends Higher patient inflows driven by strong volume momentum at legacy facilities and the integration of Al Salam branch Operational Highlights1,2 Inpatients Admissions Quarterly Trend SAR mn 9M2025 9M2024 YoY, % 9M2025 LfL1 YoY, % (Admissions) Inpatient Admissions 21,920 15,014 +46% 1
Slide 7: Income Statement
Income Statement Operational efficiency drives margin improvement across gross and EBITDA levels; NPM impacted by higher Zakat, finance costs and prior-year base effects Income Statement Highlights Net Profit Development SAR mn 3Q2025 3Q2024 YoY, % 9M2025 9M2024 YoY, % (SAR mn) Revenue 412 326 +27%
Slide 8: Revenue Trends
Revenue Trends Top-line growth in 9M 2025 supported by broad-based growth across all facilities, alongside higher revenue from GOSI referrals, the integration of Al Salam and continued expansion of the ReLib platform Revenue Development1 Revenue by Business Unit (9M 2025) (SAR mn) (%) AlBalad branch
Slide 9: Costs Overview
Costs Overview Higher cost of revenues attributable to increased salaries associated with Care’s expanded operations and recent capacity additions, as well as greater medicines and consumables outlays reflecting rising volumes of surgical procedures in 9M 2025 Total Expenses Breakdown (9M 2025) Cost
Slide 10: Balance Sheet Highlights
Balance Sheet Highlights Solid balance sheet underpinned by healthy liquidity position Balance Sheet Highlights Cash Conversion Cycle1 Trend SAR mn 3Q2025 4Q2024 YtD, % (Days) Total Non-Current Assets 1,267 1,273 -0% -10% Total Current Assets 1,331 1,229 +8% Total Assets 2,598 2,502 +4% Total Shareh
Slide 11: Receivables Management
Receivables Management Rising accounts receivables balances reflect higher revenues and slower settlements versus the prior-year period Trade Receivables1 Development Trade Receivables1 Structure (end of 3Q 2025) (SAR mn) (SAR mn) 34.5% Insurance +38% 33.1% MoH & Govt 5 12 1,288 23.7% 151 GOSI 4.9%
Slide 12: Cash Flow Highlights
Cash Flow Highlights Cash flow from operations improved significantly in 9M 2025 driven by higher non-cash adjustments and a notable reduction in Zakat payments Cash Flow Highlights Cash Flow From Operations Development (SAR mn) SAR mn 3Q2025 3Q2024 YoY, % 9M2025 9M2024 YoY, % Net Profit before zaka
Slide 13: Q&A Session
Q&A Session Care Medical Earnings Presentation – 2/11/2025 13
Slide 14: Appendix
Appendix Care Medical Earnings Presentation – 2/11/2025 14
Slide 15: Operating Performance Overview (1/2)
Operating Performance Overview1 (1/2) Total Patients Trend Surgeries Trend (Thousand patients) (Thousand surgeries) +20% CAGR +11% CAGR 639 742 651 55 532 19 19 20 254 253 261 362 193 16 13 136 339 385 398 427 227 FY20 +47% FY21 +20% FY22 +2% FY23 +14% FY24 FY20 +20% FY21 +19% FY22 +1% FY23 +7% FY24
Slide 16: Operating Performance Overview (2/2)
Operating Performance Overview1 (2/2) Bed Capacity Trend Bed Occupancy Trend (Available beds) (%) +15% CAGR 80.3% 79.2% 1,128 77.6% 349 655 655 655 655 70.8% 459 68.1% 335 335 335 335 320 320 320 320 320 FY20 +0% FY21 +0% FY22 +0% FY23 +72% FY24 FY20 FY21 FY22 FY23 FY24 Rawabi branch Malaz branch Ot
Slide 17: Financial Performance Overview
Financial Performance Overview Total Revenue Trend EBITDA Trend (SAR mn) (SAR mn) +12% CAGR +20% CAGR 377 1,294 1,082 302 809 845 918 243 214 179 FY20 +5% FY21 +9% FY22 +18% FY23 +20% FY24 FY20 +19% FY21 +13% FY22 +24% FY23 +25% FY24 Net Profit Trend Margins Trend (SAR mn) (%) 35.1% +32% CAGR 29.2%
Slide 18: Contacts
Contacts Institutional investor contact Alia Balbaa Investor Relations Director abalbaa@care.med.sa +966-11-418-4488 ext. 322 Investor Relations website https://ir.care.med.sa/ Care Medical Earnings Presentation – 2/11/2025 18
Slide 19: Disclaimer
Disclaimer All information included in this document is for general use only and has not been independently verified, nor does it constitute or form part of any invitation or inducement to engage in any investment activity, nor does it constitute an offer or invitation or recommendation to buy or su
National Medical Care Company (Care) — 9M 2025 Earnings Presentation on 6ix